New PET tracer could spot hidden brain tumors in cancer patients
NCT ID NCT03331601
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a special radioactive tracer (68GaNOTA-Anti-HER2 VHH1) to see if it can find HER2-positive brain metastases on PET/CT scans. Seven adult cancer patients with at least one brain lesion were enrolled. The goal was to compare tracer uptake in HER2-positive versus HER2-negative tumors to improve detection and guide treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN METASTASIZED CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Uz Brussel
Brussels, Brussels Capital, 1090, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Pre-Surgery immunotherapy prime the immune system to fight head and neck cancer?
- Can a new immune drug outsmart Hard-to-Treat tumors?
- Can a Two-Pronged attack shrink Hard-to-Treat cancers?
- Could your workout history affect your Cancer's genes?
- New combo therapy aims to stop liver cancer from coming back
- New drug combo takes on advanced cancers in early trial